The Parkinson's Disease NeuroGenebank at Scripps Clinic R... | NCT00766948

Studies
The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry

NCT00766948

Sponsor

Scripps Translational Science Institute

Status

Active, not recruiting

Last Update Posted

Jan 16, 2025Actual

Enrollment

100Estimated

Phase

Not provided

Conditions

Parkinson's Disease

Interventions

There is no intervention, this is a biorepository.

Countries

United States

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Jan 2025

Overall Recruitment Status or Expanded Access Status

Active, not recruiting

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Aug 2008

Primary Completion Date

Aug 2030Estimated

Completion Date

Aug 2030Estimated

First Submitted Date

Oct 2, 2008

First Submission Date that Met QC Criteria

Oct 2, 2008

First Posted Date

Oct 6, 2008Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Jan 15, 2025

Last Update Posted Date

Jan 16, 2025Actual

Name	Class
Scripps Health	OTHER
The Scripps Research Institute	OTHER

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Not provided

Is FDA Regulated Device

Not provided

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

By creating a neurogenebank from Parkinson's disease patients' blood donations we will ultimately be able to define genes for Parkinson's disease and other neurological conditions.

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

Retention

Enrollment

100Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
No Treatment			Other: There is no intervention, this is a biorepository.

Interventions

Name	Type	Description	Arm Group Labels	Other Names
There is no intervention, this is a biorepository.	Other	There are no interventions in this study.	No Treatment

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Neurogenetic databank	initiate a Parkinson's disease neurogenetic databank by obtaining blood samples in order to define genes for Parkinson's disease and other neurological conditions.	Study completion

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Is age 30 years or older at the time of onset of Parkinson's
Has been diagnosed with idiopathic Parkinson's Disease by a Scripps Neurologist
Is reliable, cooperative and willing to comply with all protocol-specified procedures and/or sub-study if consented or have legal representative/guardian willing to do so
Able to understand and grant informed consent or have a legal representative/ guardian who is able to do so

Exclusion Criteria:

Patient has been previously enrolled in The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry
If a blood draw would be contraindicated for any reason
Has a significant chronic medical condition (i.e. CVA, hepatic encephalopathy) which, in the investigator's option, may interfere with the patient's optimal participation in the study
Treatment with any investigational agents or devices within 30 days preceding enrollment in the study
Has undergone ECT within 90 days preceding enrollment in the study

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

30 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

Patients 30 years of age or older with the diagnosis idiopathic Parkinson's disease

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Cinnamon Bloss, PhD	Scripps Translational Science Institute and Genomic Medicine	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Scripps Clinic, Torrey Pines		La Jolla	California	92037	United States
Scripps Translational Science Institute

Condition Browse Module

MeSH Terms

ID	Term
D010300	Parkinson Disease

Ancestor Terms

ID	Term
D020734	Parkinsonian Disorders
D001480	Basal Ganglia Diseases
D001927	Brain Diseases
D002493	Central Nervous System Diseases

Browse Leaves

Not provided

Browse Branches

Not provided